ABVC BIOPHARMA INC (ABVC) Fundamental Analysis & Valuation

NASDAQ:ABVC • US00091F3047

Current stock price

1.03 USD
0 (0%)
Last:

This ABVC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. ABVC Profitability Analysis

1.1 Basic Checks

  • ABVC had negative earnings in the past year.
  • ABVC had a negative operating cash flow in the past year.
  • In the past 5 years ABVC always reported negative net income.
  • In the past 5 years ABVC always reported negative operating cash flow.
ABVC Yearly Net Income VS EBIT VS OCF VS FCFABVC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -5M -10M -15M

1.2 Ratios

  • ABVC's Return On Assets of -23.16% is fine compared to the rest of the industry. ABVC outperforms 72.23% of its industry peers.
  • ABVC has a Return On Equity of -40.73%. This is in the better half of the industry: ABVC outperforms 66.99% of its industry peers.
Industry RankSector Rank
ROA -23.16%
ROE -40.73%
ROIC N/A
ROA(3y)-67.54%
ROA(5y)-92.57%
ROE(3y)-324.06%
ROE(5y)-329.42%
ROIC(3y)N/A
ROIC(5y)N/A
ABVC Yearly ROA, ROE, ROICABVC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2K -2K -4K -6K

1.3 Margins

  • ABVC's Gross Margin of 100.00% is amongst the best of the industry. ABVC outperforms 99.61% of its industry peers.
  • ABVC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 100%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ABVC Yearly Profit, Operating, Gross MarginsABVC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -10K -20K -30K -40K -50K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. ABVC Health Analysis

2.1 Basic Checks

  • ABVC does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • ABVC has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, ABVC has more shares outstanding
  • ABVC has a better debt/assets ratio than last year.
ABVC Yearly Shares OutstandingABVC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
ABVC Yearly Total Debt VS Total AssetsABVC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M

2.2 Solvency

  • Based on the Altman-Z score of -4.18, we must say that ABVC is in the distress zone and has some risk of bankruptcy.
  • ABVC's Altman-Z score of -4.18 is on the low side compared to the rest of the industry. ABVC is outperformed by 60.19% of its industry peers.
  • A Debt/Equity ratio of 0.07 indicates that ABVC is not too dependend on debt financing.
  • ABVC has a worse Debt to Equity ratio (0.07) than 61.16% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Altman-Z -4.18
ROIC/WACCN/A
WACC9.2%
ABVC Yearly LT Debt VS Equity VS FCFABVC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M 10M

2.3 Liquidity

  • ABVC has a Current Ratio of 0.51. This is a bad value and indicates that ABVC is not financially healthy enough and could expect problems in meeting its short term obligations.
  • ABVC has a Current ratio of 0.51. This is amonst the worse of the industry: ABVC underperforms 92.23% of its industry peers.
  • ABVC has a Quick Ratio of 0.51. This is a bad value and indicates that ABVC is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of ABVC (0.50) is worse than 91.84% of its industry peers.
Industry RankSector Rank
Current Ratio 0.51
Quick Ratio 0.5
ABVC Yearly Current Assets VS Current LiabilitesABVC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. ABVC Growth Analysis

3.1 Past

  • ABVC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 73.56%, which is quite impressive.
  • ABVC shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -99.61%.
EPS 1Y (TTM)73.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-339%
Revenue 1Y (TTM)-99.61%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ABVC Yearly Revenue VS EstimatesABVC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 1M 2M 3M 4M
ABVC Yearly EPS VS EstimatesABVC Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 -1 -2 -3 -4 -5

More info and screens

Find the best growth stocksShow best growing peers

0

4. ABVC Valuation Analysis

4.1 Price/Earnings Ratio

  • ABVC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ABVC Price Earnings VS Forward Price EarningsABVC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ABVC Per share dataABVC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ABVC Dividend Analysis

5.1 Amount

  • ABVC does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ABVC Fundamentals: All Metrics, Ratios and Statistics

ABVC BIOPHARMA INC

NASDAQ:ABVC (5/1/2026, 8:08:13 PM)

1.03

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Industry Strength55.9
Industry Growth13.04
Earnings (Last)04-28
Earnings (Next)08-11
Inst Owners3.4%
Inst Owner Change0%
Ins Owners15.72%
Ins Owner Change0%
Market Cap26.20M
Revenue(TTM)2.00K
Net Income(TTM)-4.91M
Analysts43.33
Price TargetN/A
Short Float %1.43%
Short Ratio3.19
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 13101.6
P/FCF N/A
P/OCF N/A
P/B 2.17
P/tB 2.17
EV/EBITDA N/A
EPS(TTM)-0.26
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.11
FCFYN/A
OCF(TTM)-0.11
OCFYN/A
SpS0
BVpS0.47
TBVpS0.47
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -23.16%
ROE -40.73%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 100%
FCFM N/A
ROA(3y)-67.54%
ROA(5y)-92.57%
ROE(3y)-324.06%
ROE(5y)-329.42%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.51
Quick Ratio 0.5
Altman-Z -4.18
F-Score5
WACC9.2%
ROIC/WACCN/A
Cap/Depr(3y)32.44%
Cap/Depr(5y)179.46%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)73.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-339%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-99.61%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y14.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-60.78%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-60.48%
OCF growth 3YN/A
OCF growth 5YN/A

ABVC BIOPHARMA INC / ABVC Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ABVC BIOPHARMA INC (ABVC) stock?

ChartMill assigns a fundamental rating of 1 / 10 to ABVC.


Can you provide the valuation status for ABVC BIOPHARMA INC?

ChartMill assigns a valuation rating of 0 / 10 to ABVC BIOPHARMA INC (ABVC). This can be considered as Overvalued.


Can you provide the profitability details for ABVC BIOPHARMA INC?

ABVC BIOPHARMA INC (ABVC) has a profitability rating of 2 / 10.


Can you provide the financial health for ABVC stock?

The financial health rating of ABVC BIOPHARMA INC (ABVC) is 1 / 10.